Akèy › Kansè tiwoyid › Massachusetts › Boston
Etid klinik pou Kansè tiwoyid nan Boston, MA
6 etid pou Kansè tiwoyid ap chèche patisipan nan sit nan ak bò kote Boston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Ap rekriteFaz 1/2
- Dana-Farber Cancer Institute, Boston
XL092 and Cemiplimab in BRAF WT Thyroid Cancer
Ap rekriteFaz 1
- Dana Farber/Harvard Cancer Center, Boston
Hereditary Risk Factors for Thyroid Cancer
Ap rekriteVolontè an sante akeyi
- Dana Farber Cancer Institute, Boston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Ap rekriteFaz 1/2
- Massachusetts General Hospital,, Boston
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Ap rekriteFaz 1/2
- Massachusetts General Hospital, Boston
Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC
Ap rekriteFaz 2
- Massachusetts General Hospital, Boston
Etid Kansè tiwoyid nan lòt vil
- Houston, TX12 etid
- Washington, DC10 etid
- New York City, NY9 etid
- Philadelphia, PA6 etid
- Nashville, TN5 etid
- Durham, NC5 etid
- Los Angeles, CA5 etid
- San Francisco, CA4 etid
- San Antonio, TX4 etid
- Minneapolis, MN4 etid
- St. Louis, MO4 etid
- Memphis, TN4 etid
Lòt etid nan Boston
- Kansè nan tete111 etid
- Kansè Poumon ki pa ti selil90 etid
- Kansè (tout kalite)86 etid
- Kansè kolorektal63 etid
- Kansè Metastatik63 etid
- Kansè poumon62 etid
- Kansè ovè61 etid
- Kansè pwostat59 etid
- Depresyon52 etid
- Kansè Endomèt50 etid
- Ensifizyans kadyak44 etid
- Leksemi mieloïd egi44 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.